Aurora kinase A mediates c-Myc's oncogenic effects in hepatocellular carcinoma

Molecular Carcinogenesis

Volumn 54, Issue 11, 2015, Pages 1467-1479

  Lu, Longfeng ^a   Han, Han ^a   Tian, Yuan ^a   Li, Wenjuan ^a   Zhang, Jinxiang ^b   Feng, Maohui ^a   Li, Youjun ^a  

^a WUHAN UNIVERSITY   (China)

^b UNION HOSPITAL   (China)

Author keywords

Aurora kinase A; Autophagy; C Myc; Hepatocellular carcinoma; Malignant phenotypes

Indexed keywords

ADENOSINE TRIPHOSPHATE; AURORA A KINASE; MYC PROTEIN; SHORT HAIRPIN RNA; AURKA PROTEIN, HUMAN; MYC PROTEIN, HUMAN;

AGAR MEDIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL NUCLEUS; CONTROLLED STUDY; CPG ISLAND; DNA STRUCTURE; DOWN REGULATION; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; NUCLEAR HYPERSENSITIVE ELEMENT; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CARCINOGENESIS; CELL PROLIFERATION; GENETICS; HEPG2 CELL LINE; LIVER TUMOR; NUDE MOUSE; TUMOR CELL LINE;

ANIMALS; AURORA KINASE A; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CPG ISLANDS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; UP-REGULATION;

EID: 84945218015     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22223     Document Type: Article

References (46)

1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012; 379:1245-1255.
2. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002; 31:339-346.
3. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: From genes to environment. Nat Rev Cancer 2006; 6:674-687.
4. Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer 2008; 8:976-990.
5. Dang CV. MYC on the path to cancer. Cell 2012; 149:22-35.
6. Gao P, Tchernyshyov I, Chang TC, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009; 458:762-765.
7. Zippo A, De Robertis A, Serafini R, Oliviero S. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation. Nat Cell Biol 2007; 9:932-944.
8. Secombe J, Li L, Carlos L, Eisenman RN. The trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes Dev 2007; 21:537-551.
9. Baudino TA, McKay C, Pendeville-Samain H, et al. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev 2002; 16:2530-2543.
10. Laurenti E, Wilson A, Trumpp A. Myc's other life: Stem cells and beyond. Curr Opin Cell Biol 2009; 21:844-854.
11. Baena E, Gandarillas A, Vallespinós M, et al. c-Myc regulates cell size and ploidy but is not essential for postnatal proliferation in liver. Proc Natl Acad Sci U S A 2005; 102:7286-7291.
12. Buendia M, Cairo S. Myc target miRs and liver cancer: Small molecules to get Myc sick. Gastroenterology 2012; 142:214-218.
13. Shachaf CM, Kopelman AM, Arvanitis C, et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 2004; 431:1112-1117.
14. Nesbit CE, Tersak JM, Prochownik EV. MYC oncogenes and human neoplastic disease. Oncogene 1999; 18:3004-3016.
15. Chan KL, Guan XY, Ng IO. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma. Hum Pathol 2004; 35:1324-1331.
16. Lin CP, Liu CR, Lee CN, Chan TS, Liu HE. Targeting c-Myc as a novel approach for hepatocellular carcinoma. World J Hepatol 2010; 2:16-20.
17. Meraldi P, Honda R, Nigg EA. Aurora kinases link chromosome segregation and cell division to cancer susceptibility. Curr Opin Genet Dev 2004; 14:29-36.
18. Mahen R, Venkitaraman AR. Pattern formation in centrosome assembly. Curr Opin Cell Biol 2012; 24:14-23.
19. Marumoto T, Zhang D, Saya H. Aurora-A-a guardian of poles. Nat Rev Cancer 2005; 5:42-50.
20. Lens SM, Voest EE, Medema RH. Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat Rev Cancer 2010; 10:825-841.
21. Dar AA, Belkhiri A, Ecsedy J. Aurora kinase A inhibition leads to p73-dependent apoptosis in p53-deficient cancer cells. Cancer Res 2008; 68:8998-9004.
22. Katayama H, Sasai K, Kawai H. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 2004; 36:55-62.
23. Katsha A, Soutto M, Sehdev V, et al. Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia. Gastroenterology 2013; 145:1312-1322.
24. Yang H, Ou CC, Feldman RI, Nicosia SV, Kruk PA, Cheng JQ. Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells. Cancer Res 2004; 64:463-467.
25. Torchia EC, Caulin C, Acin S, et al. Myc Aurora Kinase A, and mutant p53 (R172H) co-operate in a mouse model of metastatic skin carcinoma. Oncogene 2012; 31:2680-2690.
26. Den Hollander J, Rimpi S, Doherty JR, et al. Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state. Blood 2010; 116:1498-1505.
27. Otto T, Horn S, Brockmann M, et al. Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma. Cancer Cell 2009; 15:67-78.
28. Brockmann M, Poon E, Berry T, et al. Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma. Cancer Cell 2013; 24:75-89.
29. Napoli S, Pastori C, Magistri M, Carbone GM, Catapano CV. Promoter-specific transcriptional interference and c-myc gene silencing by siRNAs in human cells. EMBO J 2009; 28:1708-1719.
30. Hata T, Furukawa T, Sunamura M, et al. RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. Cancer Res 2005; 65:2899-2905.
31. Kawamori D, Kajimoto Y, Kaneto H, et al. Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH2-terminal kinase. Diabetes 2003; 52:2896-2904.
32. Wu L, Beito T, Chen J. Generation and characterization of novel monoclonal antibodies against human aurora-A. Hybridoma (Larchmt) 2008; 27:313-318.
33. Han H, Sun D, Li W, et al. A c-Myc-microRNA functional feedback loop affects hepatocarcinogenesis. Hepatology 2013; 57:2378-2389.
34. Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 2012; 11:709-730.
35. Jin S, White E. Role of autophagy in cancer: Management of metabolic stress. Autophagy 2007; 3:28-31.
36. Zou Z, Yuan Z, Zhang Q, et al. Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells. Autophagy 2012; 8:1798-1810.
37. Tomonaga T, Levens D. Activating transcription from single stranded DNA. Proc Natl Acad Sci U S A 1996; 93:5830-5835.
38. Pruijn GJ, van Driel W, van der Vliet PC. Nuclear factor III, a novel sequence-specific DNA-binding protein from HeLa cells stimulating adenovirus DNA replication. Nature 1986; 322:656-659.
39. Komura J, Ikehata H, Ono T. Chromatin fine structure of the c-MYC insulator element/DNase I-hypersensitive site I is not preserved during mitosis. Proc Natl Acad Sci U S A 2007; 104:15741-15746.
40. Yuan J, Minter-Dykhouse K, Lou Z. A c-Myc-SIRT1 feedback loop regulates cell growth and transformation. J Cell Biol 2009; 185:203-211.
41. Jeng YM, Peng SY, Lin CY, Hsu HC. Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res 2004; 10:2065-2071.
42. Mehra R, Serebriiskii IG, Burtness B, Astsaturov I, Golemis EA. Aurora kinases in head and neck cancer. Lancet Oncol 2013; 14:e425-435.
43. Tatsuka M, Sato S, Kanda A, et al. Oncogenic role of nuclear accumulated Aurora-A. Mol Carcinog 2009; 48:810-820.
44. Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011; 11:325-337.
45. Kim JW, Zeller KI, Wang Y, et al. Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays. Mol Cell Biol 2004; 24:5923-5936.
46. Ward PS, Thompson CB. Metabolic reprogramming: A cancer hallmark even warburg did not anticipate. Cancer Cell 2012; 21:297-308.